CN103919058A - 一种豌豆蓉 - Google Patents
一种豌豆蓉 Download PDFInfo
- Publication number
- CN103919058A CN103919058A CN201410173721.2A CN201410173721A CN103919058A CN 103919058 A CN103919058 A CN 103919058A CN 201410173721 A CN201410173721 A CN 201410173721A CN 103919058 A CN103919058 A CN 103919058A
- Authority
- CN
- China
- Prior art keywords
- pea
- mash
- rong
- dry powder
- lycopodium calvatum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 claims abstract description 36
- 201000001421 hyperglycemia Diseases 0.000 claims abstract description 29
- 230000036541 health Effects 0.000 claims abstract description 19
- 244000197580 Poria cocos Species 0.000 claims abstract description 15
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 15
- 241000110637 Cuscuta chinensis Species 0.000 claims abstract description 14
- 240000002948 Ophiopogon intermedius Species 0.000 claims abstract description 14
- 244000215777 Plumeria rubra Species 0.000 claims abstract description 14
- 235000013087 Plumeria rubra Nutrition 0.000 claims abstract description 14
- 241000195947 Lycopodium Species 0.000 claims description 35
- 239000007788 liquid Substances 0.000 claims description 30
- 239000002994 raw material Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 11
- 238000004108 freeze drying Methods 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 239000008158 vegetable oil Substances 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- 229960002675 xylitol Drugs 0.000 claims description 3
- 235000010447 xylitol Nutrition 0.000 claims description 3
- 239000000811 xylitol Substances 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 26
- 239000008280 blood Substances 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 12
- 210000004072 lung Anatomy 0.000 abstract description 11
- 210000000952 spleen Anatomy 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000002216 heart Anatomy 0.000 abstract description 4
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 230000035922 thirst Effects 0.000 abstract description 4
- 210000001835 viscera Anatomy 0.000 abstract description 4
- 239000012530 fluid Substances 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 2
- 241000195954 Lycopodium clavatum Species 0.000 abstract 2
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 241000438687 Juncus roemerianus Species 0.000 abstract 1
- 206010000269 abscess Diseases 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 230000027939 micturition Effects 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000035764 nutrition Effects 0.000 abstract 1
- 238000010791 quenching Methods 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 230000002040 relaxant effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000001502 supplementing effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 description 25
- 239000003814 drug Substances 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 9
- 230000007812 deficiency Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 108010023302 HDL Cholesterol Proteins 0.000 description 6
- 108010028554 LDL Cholesterol Proteins 0.000 description 6
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 6
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 240000001417 Vigna umbellata Species 0.000 description 5
- 235000011453 Vigna umbellata Nutrition 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000002218 hypoglycaemic effect Effects 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 240000004922 Vigna radiata Species 0.000 description 4
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 4
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 240000008669 Hedera helix Species 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 229960004580 glibenclamide Drugs 0.000 description 3
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 239000004576 sand Substances 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 201000009361 ascariasis Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000003445 biliary tract Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- ICFJFFQQTFMIBG-UHFFFAOYSA-N phenformin Chemical compound NC(=N)NC(=N)NCCC1=CC=CC=C1 ICFJFFQQTFMIBG-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 1
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 208000016253 exhaustion Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
一种豌豆蓉；本发明涉及一种预防高血糖的保健豌豆蓉；本发明提供了一种预防高血糖的保健豌豆蓉，其特征是由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%。本发明通过鸡蛋花、菟丝子、茯苓、麦门冬、灯芯草调理人体心肝脾肺肾五脏之平衡，化瘀清浊消渴，又用伸筋草舒筋活血，补气通络从而达到降血糖的目的；豌豆益中气、止泻痢、调营卫、利小便、消痈肿，常食用本发明保健豌豆蓉，即可适当补充营养，又可以预防和控制高血糖。
Description
技术领域
本发明涉及一种保健豌豆蓉，尤其是一种预防高血糖的保健豌豆蓉。
背景技术
人体摄食过多甜食或含糖饮料，当血糖值高过规定的水平时就会形成高血糖症。不合理的膳食、肥胖会导致人体调节功能发生紊乱，出现血糖水平的升高。高血糖的危害短时间、一次性的高血糖对人体无严重损害。比如在应激状态下或情绪激动、高度紧张时，可出现短暂的高血糖；一次进食大量的糖类，也可出现短暂高血糖；随后，血糖水平逐渐恢复正常。然而长期的高血糖会使全身各个组织器官发生病变，导致急慢性并发症的发生。如胰腺功能衰竭、失水、电解质紊乱、营养缺乏、抵抗力下降、肾功能受损、神经病变、眼底病变等。
人们必须从日常饮食预防控制高血糖。豌豆蓉是人们日常食用较多的糕点、面食（如面包、月饼等）中的常用馅料。豌豆蓉一般用豌豆打成粉加油、糖和其他香料做成；豌豆蓉中的糖和油比例有的糕点占到百分之三十以上，人们常吃豌豆蓉做的糕点易导致高血糖症，因此，研发和生产可预防高血糖的保健豌豆蓉成为市场需求。
豌豆味甘、性平，归脾、胃经，具有益中气、止泻痢、调营卫、利小便、消痈肿、解乳石毒之功效。豌豆还具有增强人体免疫功能：豌豆中富含人体所需的各种营养物质，尤其是含有优质蛋白质，可以提高机体的抗病能力和康复能力。豌豆的生长速度比绿豆、红豆、黄豆等快，用来做豆蓉馅料有低成本优势。
现有技术没有应用豌豆、伸筋草配制预防控制高血糖的保健豌豆蓉，口味单一而且保健功能有其局限性。如在中国专利信息中心公布的专利申请号为200610028276.6的发明——一种蓉沙馅料的制备方法，该发明公开了一种蓉沙馅料的加工方法技术，所述的蓉沙馅料的制备方法,其步骤是：a.选当年的优质白扁豆、赤豆或绿豆；b.将挑选好的白扁豆、赤豆或绿豆放在清水中浸泡5～6小时；c.将浸泡好的白扁豆、赤豆或绿豆蒸煮成酥,然后放在机器中打磨成蓉沙；d.用虑布将蓉沙去掉60～70%的水份；e.炒制：按每100kg蓉沙馅料的量放入50～65kg的白扁豆、赤豆或绿豆蓉沙、白沙糖15～25kg、麦芽糖10～20kg、植物油5～10kg、香精0～0.1kg,混合炒熟即可；该发明有其优点，也有其局限性。
发明内容
为了解决现有技术问题，本发明的目的是要提供一种预防控制高血糖的保健豌豆蓉。
技术方案：一种预防高血糖的保健豌豆蓉，由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10-20、鸡蛋花8-20、甘草3-10、菟丝子5-10、茯苓10-20、麦门冬5-10。
制法：将所述伸筋草流浸膏干粉与豌豆蓉混合均匀分装即成。
作为优化，本发明一种预防高血糖的保健豌豆蓉，由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10-20、鸡蛋花8-20、甘草3-10、菟丝子5-10、茯苓10-20、麦门冬5-10、灯心草3-5、乌梅3-10。
作为优化，本发明一种预防高血糖的保健豌豆蓉，由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10-20、鸡蛋花8-20、甘草3-10、菟丝子5-10、茯苓10-20、麦门冬5-10；所述豌豆蓉由由以下重量份的原料制成：豌豆50-70、木糖醇10-20、植物油5-15。
伸筋草，苦辛温，祛风散寒、除湿消肿、舒筋活络。《湖南药物志》记载伸筋草：甘，平。无毒，入心，肾二经，舒筋活血，补气通络。
鸡蛋花，性凉，味甘、淡；归大肠、胃经，具有润肺解毒、清热祛湿、滑肠的功效。
甘草味甘，平。归心、肺、脾、胃经。功能主治：补脾益气，清热解毒，祛痰止咳，缓急止痛，调和诸药。用于脾胃虚弱，倦怠乏力，心悸气短，咳嗽痰多，脘腹、四肢挛急疼痛，痈肿疮毒，缓解药物毒性、烈性。
菟丝子味辛甘，性平，入肝、肾二经。具有补肾益精、养肝明目、安胎的功效。
茯苓味甘、淡、性平，入药具有利水渗湿、益脾和胃、宁心安神之功用。现代医学研究：茯苓能增强机体免疫功能，茯苓多糖有明显的抗肿瘤及保肝脏作用。
麦门冬，性微甘味苦，寒,具有滋阴润肺、益胃生津、清心除烦、强阴益精、安五脏作用。
灯芯草，微寒；甘、淡；归心；肺；小肠；膀胱经。功效主治：利水通淋；清心降火。乌梅酸、涩、平，归肝、脾、肺、大肠经。【功能主治】敛肺，涩肠，生津，安蛔。用于肺虚久咳，久痢滑肠，虚热消渴，蛔厥呕吐腹痛，胆道蛔虫症（《中国药典》）。
中医认为糖尿病主要是由于素体阴虚，五脏柔弱，复因饮食不节，过食肥甘，情志失调，劳欲过度，而导致肾阴亏虚，肺胃燥热；病机重点为阴虚燥热，而以阴虚为本，燥热为标；病延日久，阴损及阳，阴阳俱虚；阴虚燥热，耗津灼液使血液粘滞，血行涩滞而成瘀；阴损及阳，阳虚寒凝，亦可导致瘀血内阳。
本发明的优点：1、本发明伸筋草辛温易伤阴血,故配用鸡蛋花、甘草调和,制其所偏，其味呈甘醇、清甜，具有舒筋通络、活血化瘀作用。
2、菟丝子补肾益精，茯苓利水渗湿、益脾和胃，麦门冬滋阴润肺、益胃生津、清心除烦，灯芯草清心降火、乌梅消渴退热，更有助于活血化瘀降血糖。
3、本发明通过鸡蛋花、菟丝子、茯苓、麦门冬、灯芯草调理人体心肝脾肺肾五脏之平衡，化瘀清浊消渴，又用伸筋草舒筋活血，补气通络从而达到降血糖的目的；豌豆益中气、止泻痢、调营卫、利小便、消痈肿，常食用本发明保健豌豆蓉，即可适当补充营养，又可以预防和控制高血糖。
4、本发明中药粉剂对肾上腺素高血糖小鼠和四氧嘧啶高血糖症小鼠具有显著的降血糖作用。 实验选用雄性和雌性小鼠各20只；分别采用肾上腺素和四氧嘧啶建立高血糖小鼠模型，再予本发明中药粉剂、格列苯脲、苯乙双胍治疗并测血糖水平。在肾上腺素诱发的高血糖症小鼠中，本发明中药粉剂能使禁食血糖[(16. 58±3. 92) mmol/L】降低到(7. 56±2. 63) mmol/L，作用与格列苯脲比较，差异无显著性意义(P>0.05)；在四氧嘧啶诱发的高血糖症小鼠中，本发明将禁食血糖【(15. 56±1. 83) mmol/L]降低到(7. 55±1.65) mmol/L，降糖作用显著优于苯乙双胍(P<0 05)，且无格列苯脲导致低血糖的副作用。结论：本发明能显著降低2种造模动物的血糖水平(P <0. 001)，并使血糖降至正常水平。
5、本发明中药粉剂经60余例确诊的糖屎病患者的临床疗效观察表明，本发明具有显著降低糖尿病者的血糖水平，使血糖恢复正常。
本发明的临床观察效果：
1.1 一般资料：选择市人民医院门诊2型糖尿病患者60例,随机分成两组。治疗组30例,男16例,女14例,年龄30～70岁,平均(50±1.5)岁,病程6个月～15年,平均(8.0±1.2)年;对照组30例,男18例,女12例,年龄29～70岁。两组一般资料比较差异无统计学意义(P>0.05),具有可比性。
1.2 病例选择：参照1999年世界卫生组织(WHO)糖尿病诊断及分型标准[1]：糖尿病症状+任意时间血浆葡萄糖水平≥11.1mmol/L（200mg/dl）。将符合上述标准的患者随机分组进行观察研究,部分服中药的患者停原中药2周后纳入观察,未服中药的患者直接纳入观察。两组患者均予糖尿病基础治疗,包括饮食控制、运动疗法和口服降糖西药,降糖西药采用二甲双胍,根据血糖情况进行药物用法和药量调整。
1.3 治疗方法：治疗组在服用二甲双胍的基础上服用本发明中药粉剂。基本方由以下重量份的原料配方组成:伸筋草10、鸡蛋花10、甘草3、菟丝子5、茯苓10、麦门冬5；每天分三次服用，每次4克。对照组常规服用二甲双胍。两组在饮食控制、运动疗法上保持一致,两组疗程均为2个月。
1.4 观察指标：治疗前后分别测定空腹血糖(FPG)、餐后血糖(2hBG)、糖化血红蛋白(HbA1c)、空腹胰岛素(FINS)、血脂(TC、TG、HDL-C、LDL-C),血糖用葡萄糖氧化酶法测定,胰岛素用放免法测定,血脂用全自动生化分析仪测定,HOMA-IR采用Haffner等[3,4]在Homa模型中计算IR的公式,即HOMA-IR=FPG×FINS/22.5(FPG单位为mmol/L,FINS单位为mU/L)。
1.5 统计学方法：采用SPSS 14.0统计分析软件进行统计学处理。计量资料采用t检验,计数资料用χ2检验。
2 结果：两组治疗前后FPG、2hBG、HbAIc、FINS及HOMA-IR的变化详见表1。由表1中我们可以看到,治疗前两组患者FPG、2hBG、HbAlc、FINS、HOMA-IR水平比较差异无统计学意义(P>0.05);治疗后两组FPG、2hBG、HbAlc、FINS、HOMA-IR水平与治疗前比较差异有统计学意义(P<0.05或P<0.01),治疗组患者上述指标与治疗前比较有显著性差异(P<0.01)。提示治疗组和对照组均能够降低糖尿病血糖,但以治疗组改善血糖更为明显。
表1 两组患者治疗前后FPG、2hBG、HbAlc、FINS及HOMA-IR的变化
注：各项指标与治疗前相比：*P<0.05，**P<0.01；治疗后两组FINS及HOMA-IR相比^P<0.05，^^P<0.01。
两组患者治疗前后TC、TG、HDL-C、LDL-C的变化见表2。从表2中我们可以看到治疗前两组患者的TC、TG、HDL-C、LDL-C水平比较差异无统计学意义(P>0.05);治疗后两组的TC、 TG、HDL-C、LDL-C水平都有明显变化,其中TC、TG、LDL-C水平与治疗前比较差异有统计学意义(P<0.05),而治疗组HDL-C水平与治疗前比较有显著性差异(P<0.01)。说明治疗组和对照组均能改善糖尿病患者的血脂水平,而以治疗组效果更为显著。
表2 两组患者治疗前后TC、TG、HDL-C、LDL-C水平含量的变化
注：各项指标与治疗前相比：*P<0.05，**P<0.01；治疗后两组各项指标相比^P<0.05，^^P<0.01。
具体实施方式
实施例1：一种预防高血糖的保健豌豆蓉，由以下配料按重量百分比组成：伸筋草流浸膏干粉5%、豌豆蓉95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10、鸡蛋花8、甘草3、菟丝子5、茯苓10、麦门冬5。
制备方法：将伸筋草流浸膏干粉与豌豆蓉混合均匀分装即成。
实施例2：一种预防高血糖的保健豌豆蓉，由以下配料按重量百分比组成：伸筋草流浸膏干粉20%、豌豆蓉80%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草15、鸡蛋花20、甘草10、菟丝子10、茯苓20、麦门冬10、灯心草5、乌梅10。
制备方法同实施例1。
实施例3：一种预防高血糖的保健豌豆蓉，由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10-20、鸡蛋花8-20、甘草3-10、菟丝子5-10、茯苓10-20、麦门冬5-10；所述豌豆蓉由由以下重量份的原料制成：豌豆50-70、木糖醇10-20、植物油5-15。
制备方法同实施例1。
Claims (3)
1.一种预防高血糖的保健豌豆蓉，其特征是由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10-20、鸡蛋花8-20、甘草3-10、菟丝子5-10、茯苓10-20、麦门冬5-10。
2.一种预防高血糖的保健豌豆蓉，其特征是由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10-20、鸡蛋花8-20、甘草3-10、菟丝子5-10、茯苓10-20、麦门冬5-10、灯心草3-5、乌梅3-10。
3.根据权利要求1所述的保健豌豆蓉，其特征是由以下配料按重量百分比组成：伸筋草流浸膏干粉5%-20%、豌豆蓉80%-95%；所述伸筋草流浸膏干粉由以下重量份的原料配方制成流浸膏后再冷冻干燥粉碎成干粉：伸筋草10-20、鸡蛋花8-20、甘草3-10、菟丝子5-10、茯苓10-20、麦门冬5-10；所述豌豆蓉由由以下重量份的原料制成：豌豆50-70、木糖醇10-20、植物油5-15。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410173721.2A CN103919058A (zh) | 2014-04-28 | 2014-04-28 | 一种豌豆蓉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410173721.2A CN103919058A (zh) | 2014-04-28 | 2014-04-28 | 一种豌豆蓉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103919058A true CN103919058A (zh) | 2014-07-16 |
Family
ID=51137642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410173721.2A Pending CN103919058A (zh) | 2014-04-28 | 2014-04-28 | 一种豌豆蓉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103919058A (zh) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102960403A (zh) * | 2012-11-29 | 2013-03-13 | 仲珉 | 保健蛋糕 |
| CN103549521A (zh) * | 2013-10-29 | 2014-02-05 | 陀金荣 | 保健栗蓉 |
| CN103549300A (zh) * | 2013-10-29 | 2014-02-05 | 陀金荣 | 保健豌豆蓉 |
-
2014
- 2014-04-28 CN CN201410173721.2A patent/CN103919058A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102960403A (zh) * | 2012-11-29 | 2013-03-13 | 仲珉 | 保健蛋糕 |
| CN103549521A (zh) * | 2013-10-29 | 2014-02-05 | 陀金荣 | 保健栗蓉 |
| CN103549300A (zh) * | 2013-10-29 | 2014-02-05 | 陀金荣 | 保健豌豆蓉 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106722985A (zh) | 一种用于稳定血糖的糖尿病病人专用食品配方 | |
| CN105901260A (zh) | 一种阿胶蜜李及其制备方法 | |
| CN103919176A (zh) | 一种龙虾肉肠 | |
| CN103907957A (zh) | 一种竹鼠肉肠 | |
| CN103919022A (zh) | 防治高血糖的保健馒头 | |
| CN103919153A (zh) | 保健鹌鹑肉肠 | |
| CN103947925A (zh) | 一种荞麦粥 | |
| CN103919162A (zh) | 一种羊肉肠 | |
| CN103919175A (zh) | 一种对虾肉肠 | |
| CN103932226A (zh) | 一种鹿肉肠 | |
| CN103919155A (zh) | 保健鸽肉肠 | |
| CN103907963A (zh) | 一种鳄鱼肉肠 | |
| CN103907970A (zh) | 一种银鱼肉丸 | |
| CN103947916A (zh) | 一种果冻 | |
| CN103931772A (zh) | 一种奶茶 | |
| CN105941566A (zh) | 一种防治糖尿病的保健饼干及其制作方法 | |
| CN103907956A (zh) | 保健马肉肠 | |
| CN103907952A (zh) | 保健鸵鸟肉肠 | |
| CN103919058A (zh) | 一种豌豆蓉 | |
| CN103919163A (zh) | 一种驴肉肠 | |
| CN103907661A (zh) | 一种防治高血糖的保健饼干 | |
| CN103918740A (zh) | 防治高血糖的预拌粉 | |
| CN103919161A (zh) | 保健猪肉肠 | |
| CN103931999A (zh) | 一种牛肉肠 | |
| CN103948082A (zh) | 一种栗蓉 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140716 |